Bepridil is potent against SARS-CoV-2 in vitro

Mostrar otras versiones (1)

Guided by a computational docking analysis, about 30 Food and Drug Administration/European Medicines Agency (FDA/EMA)-approved small-molecule medicines were characterized on their inhibition of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (M(p)(ro)). Of these small...

Descripción completa

Detalles Bibliográficos
Autores principales: Vatansever, Erol C., Yang, Kai S., Drelich, Aleksandra K., Kratch, Kaci C., Cho, Chia-Chuan, Kempaiah, Kempaiah Rayavara, Hsu, Jason C., Mellott, Drake M., Xu, Shiqing, Tseng, Chien-Te K., Liu, Wenshe Ray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2021
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958448/
https://www.ncbi.nlm.nih.gov/pubmed/33597253
http://dx.doi.org/10.1073/pnas.2012201118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958448/
https://www.ncbi.nlm.nih.gov/pubmed/33597253
http://dx.doi.org/10.1073/pnas.2012201118

Ejemplares similares